[Clinical use of heptaminol chlorhydrate]. 1961

J DERNIER, and W CLOETENS

UI MeSH Term Description Entries
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D006535 Heptaminol An amino alcohol that has been used as a myocardial stimulant and vasodilator and to relieve bronchospasm. Its most common therapeutic use is in orthostatic hypotension. The mechanism of heptaminol's therapeutic actions is not well understood although it has been suggested to affect catecholamine release or calcium metabolism. Cardiomax,Heptaminol Hydrochloride
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000605 Amino Alcohols Compounds possessing both a hydroxyl (-OH) and an amino group (-NH2). Alcohols, Amino

Related Publications

J DERNIER, and W CLOETENS
October 1967, Cahiers d'anesthesiologie,
J DERNIER, and W CLOETENS
January 1991, Annales pharmaceutiques francaises,
J DERNIER, and W CLOETENS
November 1988, Canadian journal of physiology and pharmacology,
J DERNIER, and W CLOETENS
December 1967, Lyon medical,
J DERNIER, and W CLOETENS
July 2022, European review for medical and pharmacological sciences,
J DERNIER, and W CLOETENS
April 1967, Die Medizinische Welt,
J DERNIER, and W CLOETENS
June 1961, Annales medico-psychologiques,
J DERNIER, and W CLOETENS
January 1957, Archives des maladies du coeur et des vaisseaux,
Copied contents to your clipboard!